Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects.
about
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDSDolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIVChoice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Dolutegravir as maintenance monotherapy: first experiences in HIV-1 patients.Dietary supplement interactions with antiretrovirals: a systematic review.Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products.Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference.Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low- and High-Mineral-Content Water on the Tablet in Healthy Adults.Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.A review of drug-drug interactions in older HIV-infected patients.Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection.
P2860
Q26778450-D6FC0DD6-CD6F-4D49-8A72-1D9AD7201B8DQ26799712-61150E05-70DC-44CC-8ACA-78C27C68DFDCQ36541070-D7C710AD-1FFB-4D69-B8BD-BA5491A83FC3Q38554604-F9E1A473-5DC3-416A-AFF4-02BCD19C10A3Q38750666-6616BC1E-B3E3-424B-B3FC-65E5A24E8716Q38906639-7AC63FD0-910D-4503-A90B-916CA35183D0Q38961394-6BB62D8E-41C7-4BAA-B3EF-BA6F3F1323DFQ38974893-833F86B3-E256-402F-8A72-18AD44E8EBD7Q40282068-3EFB151B-FD7B-494C-9F8B-B276D9CCAC20Q40342159-43BC719B-DDBA-40D6-B508-52B47BEF1CF4Q40499890-F430BE38-F05B-4515-8AD3-F3F108F6BB5AQ41996857-6631DFA6-F5F3-4DCF-8AEA-BCC3CB2A4B7FQ47301806-EFEFCA08-B64E-4282-81BE-1FF5A0387DF3
P2860
Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@ast
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@en
type
label
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@ast
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@en
prefLabel
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@ast
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of dolutegrav ...... nts in healthy adult subjects.
@en
P2093
Brian Wynne
Julie Borland
Stephen Piscitelli
P2860
P304
P356
10.1002/JCPH.439
P577
2014-12-30T00:00:00Z